No more disposals says Grampian
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.By RUSSELL Hotten
GRAMPIAN Holdings, the Scottish mini-conglomerate, said yesterday it had no immediate plans for further disposals among its diverse operations.
Since the sale of its Mitre sports subsidiary in May for pounds 17m, there had been talk of more sell-offs by Grampian, whose activities include the sale of jumpers and the development of cattle vaccines.
But at the announcement of Grampian's half-year results, the finance director, David McGibbon, said there were no negotiations concerning disposals or acquisitions. Nevertheless, the company clearly intends to concentrate on its successful pharmaceuticals division, and City analysts say further disposals are likely to help finance expansion in this area.
Pre-tax profits for the six months to June were pounds 10.79m ( pounds 4.12m), but this included an pounds 8.3m exceptional gain from the sale of Mitre. Taxable profits before the exceptional were pounds 2.44m ( pounds 3.37m). Grampian shares fell 16p to 90p.
The pharmaceuticals division saw profits increase from pounds 3.06m to pounds 3.30m, with turnover up 11 per cent to pounds 22.49m. The company has 11 new vaccines under development and hopes to win a licence to market a new sheep dip next spring. The retail division, which sells woolly jumpers to tourists in the Highlands, suffered losses of pounds 1.20m ( pounds 1.21m).
In the sports division, reduced spending by golfers and a cut- back on corporate sports goods by companies pushed profits down 85 per cent to pounds 160,000. Grampian has signed up the French European footballer of the year, Jean- Pierre Papin, to endorse its products on the Continent. Profits at the transport division were pounds 940,000 ( pounds 920,000).
Earnings before the exceptional gain were 2.61p (4.34p). The dividend is held at 1.7p.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments